$SYRE
Spyre Therapeutics (SYRE) Insider Trading
Spyre Therapeutics, Inc.Mid Cap$8.7B
Spyre Therapeutics insiders sold $443.0M in the last 12 months, led by Fairmount Funds Management, with no insider purchases.
View trades →
Insiders (12-Month)
7 Insiders
View trades →
Insider Buys (12-Month)
No insider buys
Latest Buy
No open-market buys on record
Politicians (12-Month)
No politician trades
Recent Insider Trades in SYRE
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELLOE+Sale10b5-1 | King-Jones Heidy | Officer | $91.03 | 28,933 | −91.0% | -$2,633,902 | Oct 3, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $90.47 | 25,000 | −23.9% | -$2,261,831 | Oct 3, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $92.01 | 15,000 | −2.7% | -$1,380,105 | Oct 2, '26 |
SELLOE+Sale10b5-1 | King-Jones Heidy | Officer | $87.35 | 28,399 | −90.9% | -$2,480,529 | Sep 4, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $88.75 | 25,732 | −24.4% | -$2,283,821 | Sep 4, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $87.29 | 15,000 | −2.6% | -$1,309,410 | Sep 4, '26 |
SELLOE+Sale10b5-1 | Albers Jeffrey W. | Director | $104.53 | 23,000 | −71.1% | -$2,404,190 | Aug 11, '26 |
SELLOE+Sale | Burrows Scott L | CFO | $95.57 | 7,500 | −7.1% | -$716,771 | Aug 5, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $95.51 | 15,000 | −2.6% | -$1,432,705 | Aug 5, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $87.74 | 7,500 | −7.1% | -$658,040 | Jul 3, '26 |
SELLOE+Sale10b5-1 | Sloan Sheldon | CMO | $87.70 | 8,334 | All | -$730,896 | Jul 3, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $87.69 | 15,000 | −2.5% | -$1,315,346 | Jul 3, '26 |
SELLOE+Sale | Burrows Scott L | CFO | $87.13 | 15,000 | −13.3% | -$1,307,000 | Jun 27, '26 |
SELL10b5-1 | Henderson Michael Thomas | Director | $100.00 | 20,000 | −22.6% | -$2,000,000 | Jun 24, '26 |
SELL | Fairmount Funds Management LLC | Director | $85.31 | 4,684,781 | −85.2% | -$399,658,667 | Jun 23, '26 |
SELLOE+Sale10b5-1 | Sloan Sheldon | CMO | $75.00 | 8,333 | All | -$624,975 | Jun 4, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $70.43 | 15,000 | −2.4% | -$1,056,486 | Jun 4, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $71.06 | 7,500 | −7.1% | -$532,937 | Jun 4, '26 |
SELL10b5-1 | Henderson Michael Thomas | Director | $74.40 | 80,000 | −47.4% | -$5,952,050 | May 9, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $71.37 | 12,500 | −11.3% | -$892,125 | May 2, '26 |
SELLOE+Sale10b5-1 | Sloan Sheldon | CMO | $71.50 | 78,333 | All | -$5,600,701 | May 2, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $71.37 | 15,000 | −2.4% | -$1,070,507 | May 2, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $49.33 | 15,000 | −2.3% | -$739,912 | Apr 4, '26 |
SELLOE+Sale10b5-1 | Sloan Sheldon | CMO | $50.00 | 7,958 | All | -$397,900 | Apr 4, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $49.34 | 7,500 | −7.1% | -$370,076 | Apr 4, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $42.19 | 15,000 | −2.3% | -$632,866 | Mar 4, '26 |
SELLOE+Sale10b5-1 | Burrows Scott L | CFO | $40.65 | 2,500 | −2.5% | -$101,620 | Mar 3, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $32.80 | 15,000 | −2.2% | -$492,045 | Feb 5, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $30.68 | 15,000 | −2.2% | -$460,134 | Jan 6, '26 |
SELL10b5-1 | Turtle Cameron | CEO | $29.02 | 15,000 | −2.1% | -$435,356 | Dec 4, '25 |
SELL10b5-1 | Turtle Cameron | CEO | $23.33 | 45,000 | −6.0% | -$1,049,778 | Nov 6, '25 |
Older than 12 months | |||||||
SELL | Burrows Scott L | CFO | $16.26 | 18,428 | −15.8% | -$299,639 | Sep 3, '25 |